Avalon GloboCare Files 8-K

Ticker: ALBT · Form: 8-K · Filed: Oct 24, 2024 · CIK: 1630212

Sentiment: neutral

Topics: 8-K, regulatory-disclosure, financial-exhibits

TL;DR

Avalon GloboCare filed an 8-K on 10/24/24 for disclosures and exhibits.

AI Summary

Avalon GloboCare Corp. filed an 8-K on October 24, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or details about the nature of the disclosure or exhibits in the provided text.

Why It Matters

This filing indicates Avalon GloboCare Corp. is making a regulatory disclosure and submitting financial exhibits, which could contain important updates for investors.

Risk Assessment

Risk Level: low — The filing is a standard procedural update and does not contain immediate negative or positive financial news.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on October 24, 2024.

In which state is Avalon GloboCare Corp. incorporated?

Avalon GloboCare Corp. is incorporated in Delaware.

What is the Commission File Number for Avalon GloboCare Corp.?

The Commission File Number for Avalon GloboCare Corp. is 001-38728.

What is the business address of Avalon GloboCare Corp.?

The business address of Avalon GloboCare Corp. is 4400 Route 9 South, Suite 3100, Freehold, NJ 07728.

Filing Stats: 587 words · 2 min read · ~2 pages · Grade level 10.4 · Accepted 2024-10-24 09:00:23

Key Financial Figures

Filing Documents

01. Financial Statement and Exhibits

Item 9.01. Financial Statement and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release of the Company dated October 24, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AVALON GLOBOCARE CORP. Dated: October 24, 2024 By: /s/ Luisa Ingargiola Name: Luisa Ingargiola Title: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing